We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+6.47%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$11B
AUM Growth
+$6.3B
Cap. Flow
-$236M
Cap. Flow %
-2.13%
Top 10 Hldgs %
41.04%
Holding
1,273
New
73
Increased
578
Reduced
348
Closed
99

Top Buys

Rank Stock Value
1
CONE
CyrusOne Inc Common Stock
CONE
+$268M
2
WPC icon
W.P. Carey
WPC
+$195M
3
SUI icon
Sun Communities
SUI
+$193M
4
VTR icon
Ventas
VTR
+$189M
5
SPG icon
Simon Property Group
SPG
+$123M

Top Sells

Rank Stock Value
1
DLR icon
Digital Realty Trust
DLR
+$308M
2
AIV
Aimco
AIV
+$175M
3
EQR icon
Equity Residential
EQR
+$159M
4
O icon
Realty Income
O
+$123M
5
HPP
Hudson Pacific Properties
HPP
+$119M

Sector Composition

Rank Sector Weight
1 Real Estate 62.34%
2 Technology 7.48%
3 Consumer Discretionary 3.58%
4 Healthcare 3.49%
5 Communication Services 3.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLLS
1126
Cellectis
CLLS
$288M
$2K ﹤0.01%
100
– –
CTMX icon
1127
CytomX Therapeutics
CTMX
$690M
$2K ﹤0.01%
285
– –
DTIL icon
1128
Precision BioSciences
DTIL
$178M
$2K ﹤0.01%
10
– –
MNKD icon
1129
MannKind Corp
MNKD
$1.19B
$2K ﹤0.01%
1,042
– –
PBYI icon
1130
Puma Biotechnology
PBYI
$398M
$2K ﹤0.01%
243
– –
RIGL icon
1131
Rigel Pharmaceuticals
RIGL
$723M
$2K ﹤0.01%
81
– –
SYRE icon
1132
Spyre Therapeutics
SYRE
$8.5B
$2K ﹤0.01%
10
+4
+67% +$740
TXMD icon
1133
TherapeuticsMD
TXMD
$23.8M
$2K ﹤0.01%
31
– –
URGN icon
1134
UroGen Pharma
URGN
$1.97B
$2K ﹤0.01%
118
– –
VYGR icon
1135
Voyager Therapeutics
VYGR
$181M
$2K ﹤0.01%
232
– –
WVE icon
1136
Wave Life Sciences
WVE
$1.12B
$2K ﹤0.01%
213
– –
SYRS
1137
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$2K ﹤0.01%
27
– –
GTHX
1138
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$2K ﹤0.01%
212
– –
BCEL
1139
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$2K ﹤0.01%
124
– –
RVLP
1140
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$2K ﹤0.01%
293
– –
RUBY
1141
DELISTED
Rubius Therapeutics, Inc
RUBY
$2K ﹤0.01%
450
– –
PRVL
1142
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$2K ﹤0.01%
192
– –
AMAG
1143
DELISTED
AMAG Pharmaceuticals
AMAG
$2K ﹤0.01%
195
– –
JCAP
1144
DELISTED
Jernigan Capital, Inc.
JCAP
$2K ﹤0.01%
+102
New +$1.63K
BDSI
1145
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$2K ﹤0.01%
507
– –
ADMA icon
1146
ADMA Biologics
ADMA
$2.02B
$1K ﹤0.01%
335
– –
AFMD
1147
DELISTED
Affimed
AFMD
$1K ﹤0.01%
43
– –
CRBP icon
1148
Corbus Pharmaceuticals
CRBP
$165M
$1K ﹤0.01%
14
– –
DBC icon
1149
Invesco DB Commodity Index Tracking Fund
DBC
$1.69B
$1K ﹤0.01%
100
– –
DNTH icon
1150
Dianthus Therapeutics
DNTH
$5.69B
$1K ﹤0.01%
14
– –
44 45
46
47 48

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q3 2020 Portfolio in Review

As of Q3 2020, Daiwa Securities Group held 1,273 positions worth $11B, up 133% from $4.74B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Daiwa Securities Group's Q3 2020 filing shows 73 new, 578 increased, 348 reduced and 99 closed positions. Its largest new stake was Global X Cloud Computing ETF: 2,004,400 shares worth $49M. The largest sale was Digital Realty Trust, an estimated $308M.

By sector, the portfolio is most concentrated in Real Estate at 62% of assets, up from 58% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q3 2020 buy was Global X Cloud Computing ETF: 2,004,400 shares worth $49M.
  • Daiwa Securities Group added most to CyrusOne Inc Common Stock in Q3 2020, an estimated $268M increase.
  • Daiwa Securities Group's biggest Q3 2020 reduction was Digital Realty Trust, cutting an estimated $308M.
  • Daiwa Securities Group fully exited BWX Technologies in Q3 2020, selling an estimated $11.3M.
  • Daiwa Securities Group's ten largest holdings make up 41% of its $11B portfolio in Q3 2020.
  • Daiwa Securities Group opened 73 new positions and closed 99 in Q3 2020.
  • Daiwa Securities Group's portfolio value rose 133% quarter-over-quarter to $11B.

Based on Daiwa Securities Group's 13F filing for Q3 2020, filed 2 Nov 2020.